We explored an innovative treatment for chronic bacterial prostatitis (CBP) by creating antibiotic-loaded nanoparticles modified with folic acid. These nanoparticles can effectively target and penetrate the prostate tissues where inflammation and pain occur.
In animal models, the folic acid-modified nanomedicine significantly alleviated pelvic pain and reduced inflammatory markers. This targeted approach enhances antibiotic delivery and improves treatment outcomes for CBP. Although the study showcases promising results, more research is needed to translate these findings to human patients.
Read More
9
Deprox 500® shows symptom improvement
Flower Pollen Extract in Association with Vitamins (Deprox 500®) Versus Serenoa repens in Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Comparative Analysis of Two Different Treatments.
We examined the effects of Flower pollen extract with vitamins (Deprox 500®) on chronic pelvic pain compared to Serenoa repens in patients diagnosed with Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS).
In a randomized controlled trial involving 63 patients, those taking Deprox 500® experienced significant improvements in their symptom scores and overall quality of life.
Notably, patients with hypertension saw an even greater reduction in symptoms. This suggests that Deprox 500® could be a beneficial treatment option for managing pelvic pain.
Read More
Most Useful Reviews
9
Joint pain relief
Has helped significantly with my joint pain.
Read More
0
Caused strong headache
I experienced a severe headache that lasted over 24 hours. Unfortunately, the anti-inflammatory painkiller didn’t alleviate the pain caused. Perhaps the dosage is too high for daily use; I might try taking half a tablet.
We explored an innovative treatment for chronic bacterial prostatitis (CBP) by creating antibiotic-loaded nanoparticles modified with folic acid. These nanoparticles can effectively target and penetrate the prostate tissues where inflammation and pain occur.
In animal models, the folic acid-modified nanomedicine significantly alleviated pelvic pain and reduced inflammatory markers. This targeted approach enhances antibiotic delivery and improves treatment outcomes for CBP. Although the study showcases promising results, more research is needed to translate these findings to human patients.
Read More
9
Deprox 500® shows symptom improvement
Flower Pollen Extract in Association with Vitamins (Deprox 500®) Versus Serenoa repens in Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Comparative Analysis of Two Different Treatments.
We examined the effects of Flower pollen extract with vitamins (Deprox 500®) on chronic pelvic pain compared to Serenoa repens in patients diagnosed with Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS).
In a randomized controlled trial involving 63 patients, those taking Deprox 500® experienced significant improvements in their symptom scores and overall quality of life.
Notably, patients with hypertension saw an even greater reduction in symptoms. This suggests that Deprox 500® could be a beneficial treatment option for managing pelvic pain.
Read More
User Reviews
USERS' SCORE
Moderately Good
Based on 2 Reviews
7.8
All Reviews
Positive Reviews
Negative Reviews
9
Joint pain relief
Has helped significantly with my joint pain.
Read More
0
Caused strong headache
I experienced a severe headache that lasted over 24 hours. Unfortunately, the anti-inflammatory painkiller didn’t alleviate the pain caused. Perhaps the dosage is too high for daily use; I might try taking half a tablet.
Read More
Frequently Asked Questions
No FAQs are available for this product and symptom.
References
Zheng J, Hu R, Yang Y, Wang Y, Wang Q, et al. Antibiotic-loaded reactive oxygen species-responsive nanomedicine for effective management of chronic bacterial prostatitis. Acta Biomater. 2022;143:471. 10.1016/j.actbio.2022.02.044
Macchione N, Bernardini P, Piacentini I, Mangiarotti B, Del Nero A. Flower Pollen Extract in Association with Vitamins (Deprox 500®) Versus Serenoa repens in Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Comparative Analysis of Two Different Treatments. Antiinflamm Antiallergy Agents Med Chem. 2019;18:151. 10.2174/1871523018666181128164252